EyePoint, Inc. Income Statement
EYPT / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
EyePoint, Inc. reported $31M in revenue and $232M in net loss for FY2025. Revenue has grown at a 14.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.4M | $43.3M | $46.0M | $41.4M | $36.9M | $20.4M | $7.5M | $3.0M | $590.0K | $1.6M | $26.6M | $3.5M | $2.1M | $23.1M | $5.0M |
| SG&A Expense | $51.6M | $52.4M | $40.1M | $34.8M | $25.6M | $17.9M | $11.2M | $11.5M | $11.2M | $9.0M | $8.1M | $7.5M | $7.2M | $7.0M | $8.1M |
| R&D Expense | $221.0M | $132.9M | $64.7M | $49.6M | $28.5M | $15.4M | $14.9M | $16.2M | $14.9M | $14.4M | $12.1M | $9.6M | $7.0M | $7.0M | $6.9M |
| Operating Income | -$243.4M | -$145.9M | -$75.1M | -$99.6M | -$55.3M | -$47.9M | -$18.6M | -$26.3M | -$18.6M | -$21.8M | $6.4M | -$13.5M | -$12.0M | $9.1M | -$10.0M |
| Interest Expense | - | - | $1.2M | $3.2M | $5.5M | $6.2M | $720.0K | $720.0K | $0 | $0 | - | - | - | - | - |
| Income Tax | $279.0K | $90.0K | $83.0K | $0 | $0 | $0 | $0 | $0 | $0 | -$155.0K | $96.0K | -$130.0K | -$117.0K | $23.0K | -$218.0K |
| Net Income | -$232.0M | -$130.9M | -$70.8M | -$102.3M | -$58.4M | -$56.8M | -$18.5M | -$53.2M | -$18.5M | -$21.5M | $6.3M | -$13.4M | -$11.9M | $8.8M | -$8.6M |
| EPS (Basic) | -$3.17 | -$2.32 | -$1.82 | -$2.03 | -$2.03 | - | - | - | $0.22 | -$0.68 | $0.22 | -$0.49 | -$0.52 | $0.48 | -$0.44 |
| EPS (Diluted) | -$3.17 | -$2.32 | -$1.82 | -$2.03 | -$2.03 | -$5.44 | -$0.52 | -$0.68 | $0.21 | -$0.68 | $0.21 | -$0.49 | -$0.52 | $0.46 | -$0.44 |
| Shares Outstanding | 82.8M | 68.3M | 49.0M | 33.9M | 33.9M | 10.9M | 95.4M | 39.4M | 34.2M | 34.2M | 29.4M | 29.3M | 23.3M | 20.7M | 19.5M |
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | -235.0% | -246.4% | -887.3% | -3148.5% | -1344.1% | 24.2% | -388.4% | -561.4% | 39.4% | - |
| Profit Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | -278.9% | -245.2% | -1795.7% | -3133.1% | -1330.1% | 23.9% | -384.5% | -555.3% | 38.0% | -173.8% |